The growing adoption of precision oncology and targeted cancer treatments is driving demand for radioligand therapies, but the market also faces several challenges. High treatment costs, complex manufacturing processes, limited availability of medical radioisotopes, and strict regulatory requirements can restrict widespread adoption. In addition, the short half-life of certain radioactive...

The increasing adoption of precision oncology is driving demand for targeted radionuclide therapies, but the market also faces several challenges. High treatment costs, limited availability of medical radioisotopes, complex manufacturing and distribution requirements, and stringent regulatory approvals can restrict market growth. In addition, the need for specialized nuclear medicine...

The increasing demand for advanced diagnostic imaging and targeted cancer treatments is driving the growth of radiopharmaceuticals, but the market also faces several challenges. High production costs, complex manufacturing processes, strict regulatory requirements, and limited availability of medical radioisotopes can create barriers for market expansion. In addition, the short half-life of...